Exploring CD19 and Neurological Complications in CAR T Therapies

This chapter discusses the supportive research environment that fosters exploration within cancer therapies, focusing on CD19-targeted CAR T cell treatments and their neurological side effects. It delves into using single-cell genomics to investigate these complications and the broader quest for safer and more effective drug targets in precision medicine.